ANTITHROMBOTIC ACTIVITY OF SBT-828 COMPOUND by V. S. Sirotenko, M. Туan

Subjects: Get full text

Vascular control over blood cells aggregation in patients with arterial hypertension with dyslipidemia by I. N. Medvedev, I. A. Skorjatina, S. Yu. Zavalishina

Subjects: Get full text

AGGREGATION PROPERTIES OF BLOOD CELLS AND VASCULAR CONTROL OVER THEM IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA by I. N. Medvedev, I. A. Skoryatina

Subjects: Get full text

ANTIPLATELET CONTROL OF VESSELS OVER THE MAIN BLOOD CELLS IN HYPERTENSIVES WITH DYSLIPIDEMIA IN COMPLEX THERAPY by I. A. Skorjatina, I. N. Medvedev, S. Yu. Zavalishina

Subjects: Get full text

HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? by E. P. PANCHENKO

Subjects: Get full text

ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS by N. A. Dmitrieva, S. N. Tolpygina

Subjects: “…antiaggregants…”
Get full text

Clopidogrel in cardiovascular disease treatment: modern clinical recommendations by I. S. Yavelov

Subjects: Get full text

Results of Preclinical Studies of 4-(2-(4-nitrophenyl)-2-oxoethyl)-1-(thietane-3-yl)-1H-1,2,4-triazole-4-th Bromide in Relation to the Hemostasis System <i>in vivo</i> by Y. Wang, N. R. Bulatova, E. E. Klen, G. A. Rozit, I. L. Nikitina, E. A. Smolyarchuk, K. A. Zavadich, I. D. Krylova, A. V. Samorodov

Subjects: Get full text

About two kinds of antithrombotic monitoring by Z. S. Barkagan

Subjects: “…antiaggregants…”
Get full text

ANALYSIS OF OUTPATIENT PHYSICIANS, PRESCRIPTION OF DISAGGREGANT THERAPY FOR PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION AND/OR CORONARY ANGIOPLASTY WITH STENT IMPLANTATION WITHIN TH... by A. V. Zagrebelnyi, S. Yu. Martsevich, M. M. Lukyanov, E. G. Pereverzeva, A. N. Vorobyev, S. S. Yakushin, S. A. Boitsov

Subjects: Get full text

RESTENOSIS AND IN-STENT STENOSIS: PATHOGENETIC MECHANISMS AND PROGNOSTIC MARKERS by G. A. Berezovskaya, V. I. Ganyukov, M. A. Karpenko

Subjects: Get full text

RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID by N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky

Subjects: Get full text

Factors Affecting The Etiology of Isolated Thalamic Infarcts And Thalamic Infarcts With Extrathalamic Involvement: The Stroke Center Experience by Eylem Özaydın Göksu, Ecem Ağdak, Mert Van, Aylin Aytekin Yeşilgöz, Şennur Delibaş Kati

Subjects: Get full text

MODERN POTENTIAL OF MYOCARDIAL INFARCTION TREATMENT IN THE POLYCLINIC SETTINGS (LECTURE) by Yu. I. Nesterov

Subjects: Get full text

ANNUAL CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY: NEW TRIALS, NEW GUIDELINES by S. Y. Martsevich, N. P. Kutishenko, L. Yu. Drozdova

Subjects: Get full text

CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES by P. J. Dovgalevsky, N. V. Furman, N. F. Puchinian

Subjects: Get full text

STROKE PREVENTION IN INTERNIST PRACTICE by D. A. Napalkov, A. V. Zhilenko

Subjects: Get full text

Comprehensive Approach to Developing Baseline Reference Ranges for Platelet Function by Olga B. Gordeeva, Maria S. Karaseva, Vasily A. Lastovka, Nato D. Vashakmadze, Margarita A. Soloshenko, Gregory V. Revunenkov, Kirill A. Valyalov, Viktor V. Altunin

Subjects: Get full text

Clinical pharmacogenetics of antiaggregants: clinical pharmacologist' point of view by D. A. Syche, A. V. Zyatenkov, B. G. Kukes

Subjects: Get full text

NATTOKINASE – USES AND BENEFITS by M. Hristova

Subjects: Get full text